GTPBP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.190400E-01
Normal-vs-Stage2
5.956400E-01
Normal-vs-Stage3
7.240400E-01
Normal-vs-Stage4
4.735700E-02
Stage1-vs-Stage2
9.255200E-01
Stage1-vs-Stage3
3.851600E-01
Stage1-vs-Stage4
5.872400E-02
Stage2-vs-Stage3
3.206000E-01
Stage2-vs-Stage4
3.258200E-02
Stage3-vs-Stage4
2.678000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.994800E-01
Normal-vs-AfricanAmerican
2.836800E-01
Normal-vs-Asian
6.358200E-01
Caucasian-vs-AfricanAmerican
6.024200E-01
Caucasian-vs-Asian
1.060420E-01
AfricanAmerican-vs-Asian
4.358200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.544000E-01
Normal-vs-Female
6.811800E-01
Male-vs-Female
7.941800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.001400E-01
Normal-vs-Age(41-60Yrs)
5.096200E-01
Normal-vs-Age(61-80Yrs)
7.135200E-01
Normal-vs-Age(81-100Yrs)
4.878800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.206200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.538600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.870000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.175390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.011800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.554800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.928000E-01
Normal-vs-Daily Drinker
7.125200E-01
Normal-vs-Weekly Drinker
5.387800E-01
Normal-vs-Occasional Drinker
3.300800E-01
Normal-vs-Social Drinker
9.729400E-01
Non Drinker-vs-Daily Drinker
7.219000E-01
Non Drinker-vs-Weekly Drinker
7.996200E-01
Non Drinker-vs-Occasional Drinker
9.022800E-01
Non Drinker-vs-Social Drinker
2.725800E-01
Daily Drinker-vs-Weekly Drinker
8.780200E-01
Daily Drinker-vs-Occasional Drinker
5.305200E-01
Daily Drinker-vs-Social Drinker
4.318600E-01
Weekly Drinker-vs-Occasional Drinker
6.016400E-01
Weekly Drinker-vs-Social Drinker
2.790800E-01
Occasional Drinker-vs-Social Drinker
8.844200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.966800E-01
Normal-vs-Grade 2
6.241800E-01
Normal-vs-Grade 3
2.713200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.927570E-02
Grade 1-vs-Grade 3
1.863940E-02
Grade 1-vs-Grade 4
4.966800E-01
Grade 2-vs-Grade 3
3.291800E-01
Grade 2-vs-Grade 4
6.241800E-01
Grade 3-vs-Grade 4
2.713200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.312400E-01
Normal-vs-NonDiabetic
7.592400E-01
Diabetic-vs-NonDiabetic
4.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.403600E-01
Normal-vs-NoPancreatitis
7.015800E-01
Pancreatitis-vs-NoPancreatitis
6.560600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.379400E-01
Normal-vs-N1
6.166000E-01
N0-vs-N1
9.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.189000E-01
Normal-vs-TP53-NonMutant
9.898600E-01
TP53-Mutant-vs-TP53-NonMutant
8.246700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
